Cilostazol Tablet
Product Images NDC 71610-813

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 71610-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 813 26)

Label (71610 813 26)
cilostazol 100 mg oral tablets packaging label for a bottle containing 1200 tablets. Label includes storage instructions to keep at 20-25°C and protect from light, a warning to keep out of reach of children, and manufacturing details from Aphena Pharma Solutions - Tennessee, LLC in Pulaski, TN. The label displays the product NDC 71610-813-26 and batch number 18.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A pharmacokinetic curve showing plasma concentration (ng/mL) over time (hours) for cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol. The graph plots concentration profiles up to 24 hours, illustrating peak levels and decline for each compound.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A bar chart illustrating mean percent improvement in maximal walking distance across eight clinical trials comparing placebo, cilostazol 50 mg b.i.d., and cilostazol 100 mg b.i.d. The x-axis lists trial numbers with respective sample sizes and durations, while the y-axis shows percent improvement ranging from -20% to 120%. Bars represent results for each treatment group in each trial.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of cilostazol, showing the molecular connectivity and arrangement of atoms in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.